Search

Nancy J. Leith

Examiner (ID: 12198, Phone: (313)446-4874 , Office: P/1636 )

Most Active Art Unit
1636
Art Unit(s)
1636, 1811, 1815, 1941, 1805
Total Applications
1445
Issued Applications
999
Pending Applications
194
Abandoned Applications
284

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 12624951 [patent_doc_number] => 20180100147 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-04-12 [patent_title] => METHODS AND COMPOSITIONS FOR GENERATING CRISPR GUIDE RNA LIBRARIES [patent_app_type] => utility [patent_app_number] => 15/727279 [patent_app_country] => US [patent_app_date] => 2017-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19297 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15727279 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/727279
Methods and compositions for generating CRISPR guide RNA libraries Oct 5, 2017 Issued
Array ( [id] => 16484283 [patent_doc_number] => 20200377884 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-03 [patent_title] => CRISPR Fluorescent Guide RNA (fgRNA) to Understanding gRNAs Expressed from Pol II Promotors [patent_app_type] => utility [patent_app_number] => 16/632792 [patent_app_country] => US [patent_app_date] => 2017-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4732 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16632792 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/632792
CRISPR fluorescent guide RNA (fgRNA) to understanding gRNAs expressed from pol II promotors Sep 28, 2017 Issued
Array ( [id] => 16549960 [patent_doc_number] => 10883109 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-01-05 [patent_title] => Methods of modulating mRNA stability and protein expression [patent_app_type] => utility [patent_app_number] => 15/713081 [patent_app_country] => US [patent_app_date] => 2017-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 31 [patent_no_of_words] => 18813 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 298 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15713081 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/713081
Methods of modulating mRNA stability and protein expression Sep 21, 2017 Issued
Array ( [id] => 16549960 [patent_doc_number] => 10883109 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-01-05 [patent_title] => Methods of modulating mRNA stability and protein expression [patent_app_type] => utility [patent_app_number] => 15/713081 [patent_app_country] => US [patent_app_date] => 2017-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 31 [patent_no_of_words] => 18813 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 298 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15713081 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/713081
Methods of modulating mRNA stability and protein expression Sep 21, 2017 Issued
Array ( [id] => 12125142 [patent_doc_number] => 20180008728 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-01-11 [patent_title] => 'Eukaryotic Cells with Artificial Endosymbionts for Multimodal Detection' [patent_app_type] => utility [patent_app_number] => 15/709908 [patent_app_country] => US [patent_app_date] => 2017-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 22746 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15709908 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/709908
Eukaryotic Cells with Artificial Endosymbionts for Multimodal Detection Sep 19, 2017 Abandoned
Array ( [id] => 12126569 [patent_doc_number] => 20180010152 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-01-11 [patent_title] => 'NOVEL DNA-BINDING PROTEINS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 15/709969 [patent_app_country] => US [patent_app_date] => 2017-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 65939 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15709969 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/709969
DNA-binding proteins and uses thereof Sep 19, 2017 Issued
Array ( [id] => 18545503 [patent_doc_number] => 11718844 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-08-08 [patent_title] => Mirac proteins [patent_app_type] => utility [patent_app_number] => 15/699543 [patent_app_country] => US [patent_app_date] => 2017-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27209 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 378 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15699543 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/699543
Mirac proteins Sep 7, 2017 Issued
Array ( [id] => 13703243 [patent_doc_number] => 20170362576 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-12-21 [patent_title] => Host Cell Modification with Artificial Endosymbionts [patent_app_type] => utility [patent_app_number] => 15/694085 [patent_app_country] => US [patent_app_date] => 2017-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17263 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15694085 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/694085
Host cell modification with artificial endosymbionts Aug 31, 2017 Issued
Array ( [id] => 13736565 [patent_doc_number] => 20180372750 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-27 [patent_title] => ANTIBODY AND ANTIBODY MIMETIC FOR VISUALIZATION AND ABLATION OF ENDOGENOUS PROTEINS [patent_app_type] => utility [patent_app_number] => 15/688635 [patent_app_country] => US [patent_app_date] => 2017-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19394 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15688635 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/688635
ANTIBODY AND ANTIBODY MIMETIC FOR VISUALIZATION AND ABLATION OF ENDOGENOUS PROTEINS Aug 27, 2017 Abandoned
Array ( [id] => 17287220 [patent_doc_number] => 11203761 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-12-21 [patent_title] => Genetically engineered Vibrio sp. and uses thereof [patent_app_type] => utility [patent_app_number] => 15/687373 [patent_app_country] => US [patent_app_date] => 2017-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 24 [patent_no_of_words] => 19281 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15687373 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/687373
Genetically engineered Vibrio sp. and uses thereof Aug 24, 2017 Issued
Array ( [id] => 16298020 [patent_doc_number] => 20200283743 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-09-10 [patent_title] => NOVEL CRISPR ENZYMES AND SYSTEMS [patent_app_type] => utility [patent_app_number] => 16/325892 [patent_app_country] => US [patent_app_date] => 2017-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 196840 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -2 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16325892 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/325892
NOVEL CRISPR ENZYMES AND SYSTEMS Aug 16, 2017 Pending
Array ( [id] => 15619415 [patent_doc_number] => 20200080112 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-03-12 [patent_title] => NOVEL CRISPR ENZYMES AND SYSTEMS [patent_app_type] => utility [patent_app_number] => 16/325898 [patent_app_country] => US [patent_app_date] => 2017-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 220750 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16325898 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/325898
Crispr enzymes and systems Aug 16, 2017 Issued
Array ( [id] => 12092813 [patent_doc_number] => 20170349906 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-12-07 [patent_title] => 'EXPRESSION CONSTRUCTS AND METHODS OF GENETICALLY ENGINEERING METHYLOTROPHIC YEAST' [patent_app_type] => utility [patent_app_number] => 15/678342 [patent_app_country] => US [patent_app_date] => 2017-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 14419 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15678342 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/678342
Expression constructs and methods of genetically engineering methylotrophic yeast Aug 15, 2017 Issued
Array ( [id] => 12980698 [patent_doc_number] => 20170342442 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-30 [patent_title] => RECOMBINANT SELF-REPLICATING POLYCISTRONIC RNA MOLECULES [patent_app_type] => utility [patent_app_number] => 15/677435 [patent_app_country] => US [patent_app_date] => 2017-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26370 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 203 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15677435 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/677435
RECOMBINANT SELF-REPLICATING POLYCISTRONIC RNA MOLECULES Aug 14, 2017 Abandoned
Array ( [id] => 14291805 [patent_doc_number] => 10286010 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-05-14 [patent_title] => Methods of treating neurodegenerative conditions [patent_app_type] => utility [patent_app_number] => 15/661281 [patent_app_country] => US [patent_app_date] => 2017-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 18 [patent_no_of_words] => 17273 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15661281 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/661281
Methods of treating neurodegenerative conditions Jul 26, 2017 Issued
Array ( [id] => 15557505 [patent_doc_number] => 20200063164 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-02-27 [patent_title] => GENOME EDITING [patent_app_type] => utility [patent_app_number] => 16/311265 [patent_app_country] => US [patent_app_date] => 2017-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26985 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16311265 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/311265
Genome editing Jul 26, 2017 Issued
Array ( [id] => 14407581 [patent_doc_number] => 20190169634 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-06 [patent_title] => GENETIC ERASERS [patent_app_type] => utility [patent_app_number] => 16/319786 [patent_app_country] => US [patent_app_date] => 2017-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15599 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -115 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16319786 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/319786
GENETIC ERASERS Jul 25, 2017 Abandoned
Array ( [id] => 12728776 [patent_doc_number] => 20180134759 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-05-17 [patent_title] => METHODS FOR GENERATING ENDOGENOUSLY TAGGED PROTEINS [patent_app_type] => utility [patent_app_number] => 15/654419 [patent_app_country] => US [patent_app_date] => 2017-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16578 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15654419 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/654419
METHODS FOR GENERATING ENDOGENOUSLY TAGGED PROTEINS Jul 18, 2017 Abandoned
Array ( [id] => 14535241 [patent_doc_number] => 20190203242 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-07-04 [patent_title] => SCALABLE BIOTECHNOLOGICAL PRODUCTION OF DNA SINGLE STRAND MOLECULES OF DEFINED SEQUENCE AND LENGTH [patent_app_type] => utility [patent_app_number] => 16/329495 [patent_app_country] => US [patent_app_date] => 2017-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6310 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16329495 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/329495
Scalable biotechnological production of DNA single strand molecules of defined sequence and length Jul 16, 2017 Issued
Array ( [id] => 15574595 [patent_doc_number] => 10577667 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-03-03 [patent_title] => Systems and methods for microbial toxin detection [patent_app_type] => utility [patent_app_number] => 15/646177 [patent_app_country] => US [patent_app_date] => 2017-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 16 [patent_no_of_words] => 9444 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 220 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15646177 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/646177
Systems and methods for microbial toxin detection Jul 10, 2017 Issued
Menu